Aardvark Therapeutics, Inc. (AARD)
1.35
+0.18
(+15.38%)
USD |
NASDAQ |
Nov 09, 11:48
Aardvark Therapeutics Debt to Equity Ratio : 0.0091 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0091 |
| March 31, 2026 | 0.0039 |
| December 31, 2025 | 0.0041 |
| September 30, 2025 | 0.0045 |
| June 30, 2025 | 0.0047 |
| March 31, 2025 | 0.0048 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0108 |
| September 30, 2024 | 0.0108 |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -1.266 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5477 |
| Bristol Myers Squibb Co. | 1.915 |
| ANI Pharmaceuticals, Inc. | 0.9531 |
| Corcept Therapeutics, Inc. | 0.0108 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.46M |
| Total Liabilities (Quarterly) | 6.663M |
| Shareholders Equity (Quarterly) | 74.80M |
| Current Ratio | 12.63 |
| Net Debt Paydown Yield | 0.01% |